Mixtard 50/50 100 Iu Injection 10 Ml
Mixtard 50/50 100 Iu Injection 10 Ml
Mixtard 50/50 100 Iu Injection 10 Ml
Mixtard 50/50 100 Iu Injection 10 Ml

Mixtard 50/50 100 Iu Injection 10 Ml

Pack of 10 ML

MRP ₹410

₹328

₹41/ML

20% off
*MRP inclusive of all taxes

100% genuine medicines

Safe & secure payments

Safe packing and storage

Non returnable productView policy

Prescription required for this medicine

Store in refrigerator or (2° - 8° C) Do Not Freeze

About Mixtard 50/50 100 Iu Injection 10 Ml

Mixtard 50/50 100 Iu Injection 10 Ml is a mixed insulin used to control blood sugar in adults with diabetes who need insulin, giving both a fast start and a longer, steadier effect to cover meals and the time between them.

It contains a mix of fast-acting and intermediate-acting insulin. It works by replacing the insulin the body needs to move sugar from the blood into the cells.

Inject it under the skin as prescribed, usually shortly before a meal, rotating the injection site each time. Do not stop it without medical advice.

Watch for low blood sugar, especially if a meal is missed or delayed or after extra activity, and keep a sugary snack to hand. Tell your doctor about any change to your routine, and never change the dose without advice.

Last Updated On 09 Sep. 2026 | 4:33PM (IST)

Certified Content

Written by

Dr. Nikhil Ambatkar
Dr. Nikhil Ambatkar
Medical Content Reviewer | 8 years

PhD (Biotechnology)

Reviewed by

Pragati Bhosale
Pragati Bhosale
Medical Content Reviewer | 5 years

M. Pharmacy

Check out Editorial Policy

Manufacturer details

Kanankia space, 215 Atrium, 708, 7th floor A wing, Andheri - Kurla Rd, Andheri East, Mumbai, Maharashtra 400069

Country of origin: INDIA
Expiry on or after: January 2027
In case of any issues, contact us:
support@truemeds.in|09240250346
Address: 6th floor, Urmi Corporate Park Solaris, Saki Vihar Road, Andheri East, Mumbai 400071

References

  • U.S. Food and Drug Administration. (2019). Insugen Clinical Pharmacology Review. Retrieved 1 April 2024, from https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/208157Orig1s000PharmR.pdf 
  • Davidson, J., Vexiau, P., Cucinotta, D., Vaz, J., & Kawamori, R. (2005). Biphasic insulin aspart 30: literature review of adverse events associated with treatment. Clinical therapeutics, 27 Suppl B, S75–S88. https://doi.org/10.1016/j.clinthera.2005.11.022 
  • Liebl, A., Mohan, V., Yang, W., Strojek, K., & Linjawi, S. (2018). 15 Years of Experience with Biphasic Insulin Aspart 30 in Type 2 Diabetes. Drugs in R&D, 18(1), 27–39. https://doi.org/10.1007/s40268-018-0228-x 
  • National Center for Biotechnology Information (2024). PubChem Substance Record for SID 96024770, Insulin injection, biphasic isophane (BAN), Source: KEGG. Retrieved November 19, 2024 from https://pubchem.ncbi.nlm.nih.gov/substance/96024770 
  • Rys, P., Wojciechowski, P., Siejka, S., Małecki, P., Hak, L., & Malecki, M. T. (2014). A comparison of biphasic insulin aspart and insulin glargine administered with oral antidiabetic drugs in type 2 diabetes mellitus--a systematic review and meta-analysis. International journal of clinical practice, 68(3), 304–313. https://doi.org/10.1111/ijcp.12337 
Was this product description useful?
12 people find this information helpful

Disclaimer

We, at Truemeds make a diligent attempt to deliver accurate, expert- drafted and thoroughly reviewed medicine related information to our consumers. However, it should, by no means, be considered a substitute for prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact we detest any form of self medication without expert advice. The sole purpose of the information on our portal is to educate our consumers, which helps improve the communication between a doctor and a patient. The information by no means is complete in its entirety and should not be used to diagnose or treat any medical condition. No amount of information can replace the experience and expertise of a doctor, therefore his/her advice always holds priority and should be followed appropriately.

More Products By Novo Nordisk India Pvt Ltd

Novofine 32G 4 Mm Needle 100
Novofine 32G 4 Mm Needle 100
MRP₹1712.91
₹1712.91

Subscribe

Claim your complimentary health and fitness tips subscription and stay updated on our newest promotions.

Registered Office Address

Intellihealth Solutions Private Limited
Unit-301 & 304, Lightbridge Tunga Village, Saki Vihar Rd, Chandivali, Powai, Mumbai, Maharashtra, India, 400072.
CIN: U62099MH2019PTC320566
Telephone:09240250346

Grievance Officer

Name: Kishor Kumar

Download Truemeds

Manage your health with ease Download Truemeds today!Get easy access to medicine refills, health information, and more. With our app, you'll never have to wait in line again. Download now and start taking control of your health.
Playstore
Apple App  Store

Contact Us

Our customer representative team is available 7 days a week from 9 am - 9 pm.


v4.28.13

copyright

2026 - Truemeds | All rights reserved. Our content is for informational purposes only. See additional information.

Trust Certified

Our Payment Partners

paymentPartnerpaymentPartnerpaymentPartnerpaymentPartner
paymentPartnerpaymentPartnerpaymentPartnerpaymentPartner